Sign in
4

Changes in Ownership

Acrivon Therapeutics, Inc. Filed Acc 0000905148-24-003295

Options or other derivatives

  • Chief Legal Officer acquired 67,567 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Miller Mary Chief Legal Officer 2024-03-01 Grant or award · Stock Option (Right to Buy) +67,567 67,567 D: show line 1 in the form
Loading xslF345X05/form4.xml…